首页> 外文OA文献 >Peripheral Blood Autoantibodies Against to Tumor-Associated Antigen Predict Clinical Outcome to Immune Checkpoint Inhibitor-Based Treatment in Advanced Non-Small Cell Lung Cancer

【2h】

Peripheral Blood Autoantibodies Against to Tumor-Associated Antigen Predict Clinical Outcome to Immune Checkpoint Inhibitor-Based Treatment in Advanced Non-Small Cell Lung Cancer

机译：对肿瘤相关抗原的外周血自身抗体预测免疫检查点抑制剂的临床结果在先进的非小细胞肺癌中的治疗

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Juan Zhou; Jing Zhao; Qingzhu Jia; Qian Chu; Fei Zhou; Xiangling Chu; Wencheng Zhao; Shengxiang Ren; Caicun Zhou; Chunxia Su;
展开▼
作者单位

展开▼
年度 2021
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Peripheral Blood Markers Identify Risk of Immune-Related Toxicity in Advanced Non-Small Cell Lung Cancer Treated with Immune-Checkpoint Inhibitors [J] . Alberto Pavan, Laura Bonanno, Lorenzo Calvetti, The oncologist . 2019,第8期

机译：外周血标记识别用免疫检查点抑制剂治疗的晚期非小细胞肺癌中免疫相关毒性风险
2. Peripheral blood markers predictive of outcome and immune-related adverse events in advanced non-small cell lung cancer treated with PD-1 inhibitors [J] . Peng Lihong, Wang Yong, Liu Fen, Cancer immunology, immunotherapy : . 2020,第9期

机译：用PD-1抑制剂处理的晚期非小细胞肺癌中的结果和免疫相关不良事件的外周血标记物预测性
3. Distinctive germline expression of class I human leukocyte antigen (HLA) alleles and DRB1 heterozygosis predict the outcome of patients with non-small cell lung cancer receiving PD-1/PD-L1 immune checkpoint blockade [J] . Pierpaolo Correale, Rita Emilena Saladino, Diana Giannarelli, Journal for ImmunoTherapy of Cancer . 2020,第1期

机译：I类人白细胞抗原（HLA）等位基因和DRB1杂小亢进的独特种系表达预测了接受PD-1 / PD-L1免疫检查点封闭的非小细胞肺癌患者的结果
4. A proteomic signature of relapse-related death predicting clinical outcome in human non-small cell lung cancer [C] . Kiyoshi Yanagisawa M.D., Shuta Tomida, Yukako Shimada, ASMS Conference on Mass Spectrometry and Allied Topics . 2006

机译：复发相关死亡的蛋白质组学特征预测人非小细胞肺癌临床结果
5. Pre-Treatment Radiomics Models for Clinical Outcomes in Early-Stage Non-Small Cell Lung Cancer (NSCLC) [D] . Shaffer, Nathan Allen. 2021

机译：早期非小细胞肺癌临床结果的预处理辐射瘤模型（NSCLC）
6. Peripheral Blood Autoantibodies Against to Tumor-Associated Antigen Predict Clinical Outcome to Immune Checkpoint Inhibitor-Based Treatment in Advanced Non-Small Cell Lung Cancer [O] . Juan Zhou, Jing Zhao, Qingzhu Jia, 2021

机译：对肿瘤相关抗原的外周血自身抗体预测免疫检查点抑制剂的临床结果在先进的非小细胞肺癌中的治疗
7. Association of baseline peripheral-blood eosinophil count with immune checkpoint inhibitor-related pneumonitis and clinical outcomes in patients with non-small cell lung cancer receiving immune checkpoint inhibitors [O] . Xiangling Chu, Jing Zhao, Juan Zhou, 2020

机译：基线外周血嗜酸性粒细胞计数与免疫检查点抑制剂相关的肺炎和非小细胞肺癌接受免疫检查点抑制剂患者的临床结果

Peripheral Blood Autoantibodies Against to Tumor-Associated Antigen Predict Clinical Outcome to Immune Checkpoint Inhibitor-Based Treatment in Advanced Non-Small Cell Lung Cancer

著录项

引文网络

相似文献

相关主题

期刊订阅